TBPH vs VRTX: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Vertex Pharmaceuticals Inc in 2026
TBPH
Theravance Biopharma Inc
—
VRTX
Vertex Pharmaceuticals Inc
$491.34
Key Metrics Comparison
| Metric | TBPH | VRTX | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $106.87B | VRTX |
| P/E Ratio | 7.49 | 29.67 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or VRTX a better investment?
Comparing TBPH and VRTX: Theravance Biopharma Inc has a market cap of $861.45M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and VRTX?
TBPH (Theravance Biopharma Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or VRTX?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 29.7x).
Which is growing faster: TBPH or VRTX?
Both TBPH and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $861.45M for TBPH.
Should I buy TBPH or VRTX in 2026?
Both TBPH and VRTX have investment merit. TBPH trades at $N/A while VRTX trades at $491.34. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and VRTX stock?
Key differences: Market Cap ($861.45M vs $106.87B), P/E Ratio (7.5x vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or VRTX in 2026?
The choice between TBPH and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and VRTX?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.